HELGA VALFELLS

Helga Valfells stands as a prominent figure in the Nordic venture capital landscape, serving as a Managing Partner at Crowberry Capital. In this crucial role, she is instrumental in shaping the future of innovation by leading investments in promising early-stage technology and innovation companies. Crowberry Capital, under her guidance, focuses on identifying groundbreaking startups primarily within Iceland and the broader Nordic region, providing them with the capital and strategic support needed to scale globally.

Helga's investment philosophy is deeply rooted in fostering disruptive technologies and sustainable solutions. Her expertise covers a broad spectrum of sectors, including but not limited to Software as a Service (SaaS), fintech, health tech, deep tech, and various sustainable innovation initiatives. She is particularly drawn to companies that demonstrate strong potential for international expansion and possess unique intellectual property or market advantages. Her strategic vision helps portfolio companies navigate the complexities of growth, from product development to market entry and fundraising.

Before co-founding Crowberry Capital, Helga Valfells built an impressive career marked by significant contributions to the financial and investment sectors. Her background includes extensive experience in investment banking, corporate finance, and mergers and acquisitions. She has been involved in the establishment and management of other successful investment funds, showcasing her profound understanding of capital markets and venture ecosystem development. This rich professional history provides her with a unique perspective on identifying viable investment opportunities and guiding entrepreneurs through their growth journeys. Helga is widely recognized for her leadership and her commitment to strengthening the Icelandic and Nordic startup ecosystems.

Crowberry Capital's portfolio, influenced by Helga's strategic insights, features a diverse array of innovative companies that are making significant impacts in their respective fields. While specific investments are a team effort, the firm's track record includes backing companies like Kerecis (biotech/medtech), Controlant (supply chain monitoring), Sidekick Health (digital therapeutics), and Oculis (ophthalmology), among others. These examples highlight Crowberry Capital's commitment to supporting high-growth companies that are developing cutting-edge solutions and aiming for global leadership. Helga Valfells's dedication to empowering founders and driving technological advancement continues to solidify her reputation as a key influencer in the venture capital world.